{
    "nct_id": "NCT06904274",
    "official_title": "A Multi-center, Open Label, Randomized Parallel Group Study Evaluating the Proportion of Post-menarchal Women With Complete Resolution of Nonatypical Endometrial Hyperplasia Treated With Mirena or Oral Progestin for 6 Months",
    "inclusion_criteria": "* Post-menarchal women (â‰¥ 16-years) at the time of signing the informed consent.\n* Women with histologically confirmed NAEH independent of their parity or menopausal status.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 16 Years",
    "exclusion_criteria": "* Any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results.\n* Congenital or acquired uterine or cervical anomaly including fibroids, or cervical stenosis that in the opinion of the investigator, would interfere with insertion and/or retention of the intrauterine system (i.e., if they distort the uterine cavity).\n* Use of any long-acting injectable sex-hormone preparations within 6 months prior to the start of study intervention, and /or short acting hormonal medication within 6 weeks prior to the start of study intervention.\n* Pregnancy\n* Participants with either known family or personal history of genetic predisposition to uterine, ovarian or colorectal cancers (e.g. Lynch syndrome).",
    "miscellaneous_criteria": ""
}